Europe High Content Screening Market Size- By Product Type, By Application, By Technology, By Distribution Channel- Regional outlook, Competitive Strategies and Segment Forecast to 2033

Description

Europe High Content Screening Market Introduction and Overview

According to SPER Market Research, 'Europe High Content Screening Market Size- By Product Type, By Application, By Technology, By Distribution Channel - Regional outlook, Competitive Strategies and Segment Forecast to 2033' States that the Europe High Content Screening Market is estimated to reach USD 1979.69 million by 2033 with a CAGR of 7.01%.

Additionally, the rising prevalence of chronic diseases and the demand for innovative treatments drive the adoption of HCS technologies to identify potential drug targets and evaluate drug efficacy. Supportive government initiatives and funding for research, along with collaborations between academic institutions and industry players, foster a conducive environment for HCS market growth.

The COVID-19 pandemic had a notable impact on the European High Content Screening (HCS) market, influencing both its challenges and opportunities. On the one hand, the pandemic accelerated the demand for HCS technologies as pharmaceutical and biotechnology companies intensified their efforts to develop vaccines, treatments, and diagnostic tools for COVID-19

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product Type, By Technology, By Application, By Distribution Channel

Regions covered Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe

Companies Covered Axxam S.p.A., BD, Carl Zeiss AG, Corning Incorporated, Merck KGaA, Molecular Devices, LLC. (Subsidiary of Danaher Corporation), PerkinElmer Inc., Sartorius AG, Thermo Fisher Scientific Inc., and Zifo RnD Solutions.

Europe High Content Screening Market Segmentation:

By Product Type: Based on the Product Type, Europe High Content Screening Market is segmented as; Instruments, Consumables, Software, Services, Accessories.

By Application: Based on the Application, Europe High Content Screening Market is segmented as; Primary and Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others.

By Technology: Based on the Technology, Europe High Content Screening Market is segmented as; Microscopy, Flow Cytometry, Extracellular Matrix Based Scaffold, Western Blotting, ELISA, Immunohistochemistry, Others.

By Region: This research also includes data for Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe.

Product Code: HLCA2468

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity, and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe High Content Screening Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Europe High Content Screening Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe High Content Screening Market

7. Europe High Content Screening Market, By Product Type (USD Million) 2020-2033

7.1. Europe High Content Screening Market Size, Share and Forecast, By Product Type, 2020-2026
7.2. Europe High Content Screening Market Size, Share and Forecast, By Product Type, 2027-2033
7.3. Instruments
7.4. Consumables
7.5. Software
7.6. Services
7.7. Accessories

8. Europe High Content Screening Market, By Application (USD Million) 2020-2033

8.1. Europe High Content Screening Market Size, Share and Forecast, By Application, 2020-2026
8.2. Europe High Content Screening Market Size, Share and Forecast, By Application, 2027-2033
8.3. Primary and Secondary Screening
8.4. Target Identification & Validation
8.5. Toxicity Studies
8.6. Compound Profiling
8.7. Others

9. Europe High Content Screening Market, By Technology (USD Million) 2020-2033

9.1. Europe High Content Screening Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Europe High Content Screening Market Size, Share and Forecast, By Technology, 2027-2033
9.3. Microscopy
9.4. Flow Cytometry
9.5. Extracellular Matrix Based Scaffold
9.6. Western Blotting
9.7. ELISA
9.8. Immunohistochemistry
9.9. Others

10. Europe High Content Screening Market, By Distribution Channel (USD Million) 2020-2033

10.1. Europe High Content Screening Market Size, Share and Forecast, Distribution Channel, 2020-2026
10.2. Europe High Content Screening Market Size, Share and Forecast, By Distribution Channel, 2027-2033
10.3. Direct Tenders
10.4. Retail Sales

11. Europe High Content Screening Market Forecast, 2020-2033 (USD Million)

11.1. Europe High Content Screening Market Size and Market Share

12. Europe High Content Screening Market, By Region, 2020-2033 (USD Million)

12.1. Europe High Content Screening Market Size and Market Share By Region (2020-2026)
12.2. Europe High Content Screening Market Size and Market Share By Region (2027-2033)
12.3. Germany
12.4. France
12.5. U.K.
12.6. Italy
12.7. Spain
12.8. Russia
12.9. Turkey
12.10. Belgium
12.11. Denmark
12.12. Netherlands
12.13. Switzerland
12.14. Sweden
12.15. Poland
12.16. Norway
12.17. Finland
12.18. Rest of Europe

13. Company Profile

13.1. Axxam S.p.A.
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
13.2. BD
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
13.3. Carl Zeiss AG
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
13.4. Corning Incorporated
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
13.5. Merck KGaA
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
13.6. Molecular Devices LLC. (Subsidiary of Danaher Corporation)
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
13.7. PerkinElmer Inc.
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
13.8. Sartorius AG
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
13.9. Thermo Fisher Scientific Inc.
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
13.10. Zifo RnD Solutions
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments